Fig. 2From: Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastasesWoman 42 years with colon cancer. Gd-BT-DO3A (a, c and e) and GD-EOB-DTPA (b, d and f) studies performed 15 days away. During Gd-BT-DO3A (a, c and e) contrast study the metastases are nor detected while after GD-EOB-DTPA (b, d and f) contrast agent the metastases are detected (arrow)Back to article page